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Available online 27 July 2011Abstract Cell therapy has enormous potential to restore neurological function after stroke.
The present study investigated effects of conditionally immortalised neural stem cells (ciNSCs), the Maudsley hippocampal
murine neural stem cell line clone 36 (MHP36), on sensorimotor and histological outcome in mice subjected to transient
middle cerebral artery occlusion (MCAO).
Adult male C57BL/6 mice underwent MCAO by intraluminal thread or sham surgery and MHP36 cells or vehicle were implanted
into ipsilateral cortex and caudate 2 days later. Functional recovery was assessed for 28 days using cylinder and ladder rung
tests and tissue analysed for plasticity, differentiation and infarct size.
MHP36-implanted animals showed accelerated and augmented functional recovery and an increase in neurons (MAP-2),
synaptic plasticity (synaptophysin) and axonal projections (GAP-43) but no difference in astrocytes (GFAP), oligodendrocytes
(CNPase), microglia (IBA-1) or lesion volumes when compared to vehicle group.
This is the first study showing a potential functional benefit of the ciNSCs, MHP36, after focal MCAO in mice, which is probably
mediated by promoting neuronal differentiation, synaptic plasticity and axonal projections and opens up opportunities for
future exploitation of genetically altered mice for dissection of mechanisms of stem cell based therapy.
© 2011 Elsevier B.V. All rights reserved.Abbreviations: MHP36, Maudsley hippocampal murine neural
stem cell line clone 36; MCAO, transient middle cerebral artery
occlusion; CBF, cerebral blood flow; NAC, N-acetyl-l-cysteine; MAP-2,
microtubule-associated protein 2; GFAP, glial fibrillary acidic protein;
CNPase, 2′,3′-cyclic-nucleotide 3′-phosphodiesterase; IBA-1, ionised
calcium binding adaptor molecule 1
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Stroke has remained a leading cause of death and neurolog-
ical disability worldwide in the past decades. According to
the World Health Organization, 15 million people suffer
stroke worldwide each year. Of these, 5 million die and
another 5 million are permanently disabled (Mackay and
Mensah, 2004). In the European Union, each year about
1.1 million people suffer a new stroke and currently 6 million
subjects live, having survived a stroke (Makinen et al., 2006)..
15Conditionally immortalised neural stem cells promote functional recovery and brain plasticityAs calculated cost per patient, stroke is the third most costly
neurological disorder (Makinen et al., 2006; Truelsen et al.,
2005). There are currently no effective treatments to
enhance functional recovery following stroke.
One of the most exciting frontiers in neuroscience is the
potential use of stem cells for treating neurodegenerative
disorders. Cell-based therapies are of particular interest in the
central nervous system, because the mature brain has little
capacity for self-repair. The plasticity exhibited by stem cells
raises the possibility that they can be used to restore function
compromised by brain insults, such as stroke (Makinen et al.,
2006; Lindvall and Kokaia, 2004; Savitz et al., 2002). Initial
studies using foetal tissue transplantation have been success-
ful in ameliorating neurodegenerative deficits in animal
experiments (Isacson et al., 1984) and this has been translated
with some success in humans (Lindvall and Kokaia, 2005).
However, further use of foetal tissue in treating human disease
is problematic due to ethical considerations and a limited
supply of tissue. In order to combat these problems, a variety
of stem cell lines have been investigated for their potential in
improving recovery in animal models of neurodegenerative
disease. These include human bone marrow stromal cells
(Chen et al., 2001), human neuroteratocarcinoma cells
(Saporta et al., 1999) and conditionally immortalised neural
stem cells (ciNSCs) (Sinden et al., 1997).
The ciNSC line, Maudsley hippocampal stem cell line clone
36 (MHP36), is derived from the embryonic stage 14 (E14)
hippocampal proliferative zone of the temperature sensitive
(tsA58) transgenic mouse, which constitutively expresses the
tumour antigen (TAg) under the control of interferon-γ
(IFNγ). MHP36 cells proliferate at low temperatures (33 °C)
in vitro since the oncoprotein is active and give rise to
various neuronal and glial precursor phenotypes at least in
part by inductive signalling. When switched to the non-
permissive temperature (37–39 °C), however, the oncopro-
tein is inactive, the cells cease division and demonstrate the
capacity to differentiate which is an important property of
the cell lines which reduces the chance of producing tumours
(Savitz et al., 2002; Sinden et al., 1997). MHP36 grafts are
well suited to repair the indiscriminate cell loss that occurs
with middle cerebral artery occlusion because previously,
they have been shown to have the capacity to differentiate
into site appropriate phenotypes in response to host signalsFigure 1 Experimental regime used for the behavioural study. Mice
day pre-surgery functional behaviour testing occurred for both tasks.
assigned a neurological score post-MCAO/sham on days 1, 3 and 4 usi
tested for behavioural function (“post-surgery behaviour”) using ladd
14 and 28.(Hodges et al., 2000a; Gray et al., 2000; Wong et al., 2005;
Modo et al., 2002a) and migrate to and engraft areas of
damage in the host brain (Gray et al., 1999; Veizovic et al.,
2001). Furthermore, they have been shown to reduce
damage in several models of neurological impairment,
including global ischaemia in mice (Wong et al., 2005),
transient middle cerebral artery occlusion (MCAO) (Hodges
et al., 2000b) and lesions to cholinergic forebrain projections
(Gray et al., 2000) in rats but mechanisms involved still need
to be clarified.
Previous MCAO studies of MHP36 cells have used rats and
assessed functional recovery using behavioural tasks (e.g.
neurological severity score, rotational bias, spontaneous
activity, bilateral asymmetry test, water maze). Improve-
ment within six weeks after administration has been
demonstrated using the bilateral asymmetry test (Modo
et al., 2002a), however recovery is incomplete. This is the
first study that investigates whether MHP36 cells promote
functional recovery after MCAO in mice utilising robust
behavioural tests known to assess spontaneous forelimb use
(Baskin et al., 2003; Fleming et al., 2004; Schallert et al.,
2000; Li et al., 2004; Starkey et al., 2005) and foot faults
(Farr et al., 2006; Metz and Whishaw, 2002; Riek-Burchardt
et al., 2004). This in the future would allow a more
mechanistic insight into how to maximise the function of
stem cells by exploiting transgenic mice after stroke.
Results
Ischaemic deficits, neurological deficits and infarct
volumes were equivalent across groups
We firstly ensured that all MCAO groups underwent similar
stroke insults. Analysis of CBF did not show any difference
between animals that later received vehicle and MHP36 stem
cells, and CBF was reduced by >85–90% in all animals during
MCAO when compared to pre-occlusion baseline values.
Acute neurological deficit, evaluated using Clark's deficit
score, was significantly greater in both the general and focal
scores post-MCAO when compared to sham animals and not
significantly different in MCAO animals that received vehicle
and MHP36 stem cells (Figs. 2A and B). At 28 days post-MCAOwere first handled before testing for 3 days each. The following
Mice underwent focal MCAO (or sham surgery) on day 0 and were
ng the Clark's deficit score (dotted lines). Further, animals were
er and cylinder tests on day 2 (prior to injection) and on days 7,
Figure 2 Acute neurological deficit scores were equivalent
across groups. Clark's deficit score assessed at 1, 3 and 4 days
post-MCAO in mice in both groups (mean±S.E.M., n=8) for (A)
general score and (B) focal score using a scale ranging from
0 (healthy) to 28.
16 S. Patkar et al.there was no significant difference in lesion volume between
the MHP36 (13.08±1.3 mm3; n=8) and vehicle (13.2±
1.97 mm3, n=8) grafted mice. The topography of the lesion
throughout the MCA territory is shown in Fig. 3.ciNSCs improved foot-fault function using the ladder
rung test
There were no significant placement errors observed on the
ladder test in sham-treated animals (Fig. 4). Prior to MCAO,
mice performed mainly correct placements with all four
limbs. There was a significant increase in foot placement
errors of the contralateral forelimb in MCAO mice at 2 days
post-MCAO (vehicle, 4.029±0.19; MHP36, 4.077±0.13,
pb0.001) when compared to pre-MCAO scores (vehicle,
5.776±0.05; MHP36, 5.734±0.04) in both MCAO injection
groups. Furthermore, this foot placement error was observed
at 7 and 14 days post MCAO surgery when compared to sham
surgery animals. There was a highly significant deficit at
28 days post-MCAO in vehicle group (4.03±0.19, pb0.001)
when compared to pre-MCAO score (vehicle, 5.77±0.05)
which was improved in the animals receiving the MHP36 cells
(pre: 5.73±0.04; 28 days: 4.95±0.12, pb0.01) (Fig. 4).
Furthermore, therewas a significant acceleration of recoveryobserved at 14 days post-MCAO (4.71±0.18, pb0.05) in
animals receiving MHP36 cells only when compared to
2 days post MCAO score. In addition, at 28 days the foot
fault scores observed between MCAO+vehicle (4.95±0.12)
and MCAO+MHP36 (4.029±0.19) animals showed a significant
trend towards improvement in the MCAO+MHP36 (p=0.049).
ciNSCs improved asymmetric score using cylinder test
Spontaneous forelimb (cylinder) task results are shown in Fig. 5.
In this task, the mean laterality score of the injured group,
which measures preference for the forelimb unaffected by
(ipsilateral to) the injury, peaked at 2 days post-MCAO time
point. There were no significant asymmetries noted in the
cylinder test in sham-treated animals (Fig. 5). There was a
significant increase in left forelimb (ipsilateral) usage at 2 days
post-MCAO (vehicle, 0.810±0.19; MHP36, 0.767±0.26,
pb0.001) when compared to pre-MCAO (vehicle, −0.021±
0.15; MHP36, 0.024±0.12) in both injection groups. In the
vehicle group there was a significant deficit between 28 days
post-MCAO score (0.46±0.1) and pre-MCAO score (pb0.05).
However in theMHP36 group the scoresbetween28 days (−0.3±
0.16) and pre-MCAO baseline were no longer significant (ns)
(Fig. 5). Furthermore, at 28 days the asymmetric score between
MCAO+vehicle and MCAO+MHP36 animals showed a significant
improvement in the MCAO+MHP36 group (pb0.001; Fig. 5).
ciNSCs promoted integration, synaptogenesis and
axonal projections
At 28 days post-MCAO staining of brain sections with
neuronal marker MAP-2, revealed an increase in expression
in the MHP36 group of animals when compared to the vehicle
group (Figs. 6A and B) (Bregma: −0.38±0.10 mm). Mean
intensity of MAP-2 expression as well as the number of MAP-2
positive neurons was significantly increased in MHP36 versus
vehicle animals (Fig. 6C). GFAP-positive astrocytes, in the
peri-lesion region which included the cortex and caudate,
showed a non-significant trend to decrease in the MHP36
group of animals when compared to vehicle (Figs. 6D, E and F)
whereas CNPase-positive oligodendrocytes showed a non-
significant trend to increase in the MHP36 group of animals
versus vehicle (Figs. 6G, H and I) and there was no significant
difference in IBA-1 positive activated-microglia cells in
MHP36 versus vehicle groups (Figs. 6J, K and L).
At 28 days post-MCAO anti-Synaptophysin (Syn) immunos-
taining was apparent in MHP36 grafted animals (Figs. 7A–C)
and co-localisation of PKH26 labelled MHP36 cells with Syn
was observed in the cortex within the peri-lesion. The mean
average intensity for Syn-positive staining and the number of
Syn-positive cells were significantly increased after MHP36
compared to vehicle and in the ipsilateral cortex when
compared to contralateral cortex in the MHP36 animals
(Fig. 7G). Furthermore, cytoplasmic marker for axonal
projections GAP-43 expression was elevated in animals
treated with MHP36 cells (Figs. 7D and E) and co-localisation
of PKH26 labelled MHP36 cells with the GAP-43 in the cortex
at 28 days post-MCAO was observed (Fig. 7F). A significant
increase in the number of synapse formation and axonal
projections was observed in animals treated with MHP36
cells when compared to vehicle (Figs. 7G and H).
Figure 3 ciNSC graft did not reduce lesion size by 28 days post-MCAO. (A) Composite images of a median representative of the
topography of lesion from animals that received either vehicle or MHP36 cells inscribed on the line diagram from the mouse atlas and
super-imposed on each other. (B) Graphical representation of the topography of lesion over eight coronal levels (0.10, 0.16, 1.98,
2.86, 3.34, 3.94, 4.66 and 6.02 mm with respect to interaural distance).
17Conditionally immortalised neural stem cells promote functional recovery and brain plasticityDiscussionCell transplantation therapy for stroke has tremendous
potential; however certain limitations are delaying their
success in humans. The key findings of the present study are
that ciNSCs, MHP36, restore lost sensorimotor function after
transient MCAO in mice as demonstrated in both the cylinder
and ladder rung tests. Improved function is not due to
reduced lesion size but possibly by increasing neuronal
differentiation and synaptic plasticity.
In a previous study, MHP36 improved functional recovery
after transient MCAO, but in that study grafting was done in
rats, at 8 distinct contralateral sites and at 2 to 3 weeks after
MCAO (Veizovic et al., 2001). In addition, MHP36 cells have
been tested in mice after 2 vessel global ischaemia and found
to reduce ischaemic damage with 50% of cells having
neuronal phenotype though no functional recovery was
assessed (Wong et al., 2005). We now extend these studiesshowing success of MHP36 cells after transient MCAO when
grafted in mice in 2 ipsilateral sites at 2 days after MCAO. The
success of MHP36 cells in mice after focal ischaemia in the
present study extends the use of these ciNSCs to genetically
altered mice for subsequent research into mechanistic
insight of these cells after stroke.
Improving functional outcome after stroke is the ultimate
goal of stroke treatment. Therefore the detection of
functional deficits is essential for potential translational
applications. Mice due to their small size and quick
movements can be perceived as more challenging to handle
and train than rats (Wahlsten et al., 2003). Test strategies
for mice are hence frequently based on evaluation of simple
motor behaviour in standard test batteries (Li et al., 2004;
Cook et al., 2002; Lalonde et al., 2003) or neurological score
such as Clark's deficit score (Clark et al., 1997; De Simoni
et al., 2003). While these tests evaluate gross behaviour,
they lack resolution when rather specific chronic deficits
need to be identified. Clark's deficit score has previously
Figure 4 ciNSC grafts augmented recovery from foot faults
after 28 days post-MCAO using ladder rung test. Stepping errors
in vehicle and MHP36 cell treated sham and MCAO mice at pre-
surgery (0 days) and at 2, 7, 14 and 28 days post-surgery (mean±
S.E.M., n=8, **pb0.01, ***pb0.001 versus pre-surgery, δpb0.05
versus 2 days, UUUpb0.001 MCAO versus sham at 7 and 14 days
post-surgery, ωpb0.05 MCAO+vehicle versus MCAO+MHP36,
repeated measure ANOVA). A score of 6 indicated correct
placements.
Figure 5 ciNSC grafts reversed spontaneous forelimb use
asymmetry by 28 days post-MCAO. Asymmetric score assessed by
cylinder test in vehicle and MHP36 cell treated sham and MCAO
mice at pre-surgery (0 days) and at 2, 7, 14 and 28 days post-
surgery (mean±S.E.M., n=8, *pb0.05, ***pb0.001 (versus pre-
surgery), δδδpb0.001 (MCAO+vehicle versus MCAO+MHP36), ns =
not significant versus pre-surgery for all groups except MCAO+
vehicle, repeated measure ANOVA).
18 S. Patkar et al.shown a significant difference between treatments up till
but not beyond 4 days post-surgery (De Simoni et al., 2003;
Storini et al., 2005). Clark's score was not designed in the
present study to differentiate between the injection groups
given acute time points (3 and 4 days post-MCAO), but
merely to evaluate if neurological deficit after MCAO was
equivalent across groups. Regarding the recovery of senso-
rimotor deficits, much less has been described in the mouse.
In rats and marmosets, tests that have shown successful
sensorimotor recovery after MCAO with MHP36 include
bilateral asymmetry and amphetamine rotation (Modo
et al., 2002a; Veizovic et al., 2001), cognitive function and
simple and conditioned discrimination (Virley et al., 1999).
Since unilateral brain damage in human and rodents results
in deficits of symmetry, we employed a test in mice that
detects asymmetries, namely the cylinder test. The advan-
tage of the cylinder test is that it can detect even mild
neurological impairments (Hua et al., 2002) and factors out
confounding variables such as overall decrease in activity
after surgical induction of stroke as additional trials can be
performed. This is the first time the cylinder test has been
used to assess the potential of MHP36 cells. We observed
symmetrical use of both paws in sham animals and a marked
preference for use of the non-impaired (ipsilateral) paw
after MCAO. Importantly, treatment with MHP36 reduced
this asymmetry [by >70%]. Therefore, we have introduced aFigure 6 Histological assessment of differentiation at 28 days pos
(A) vehicle and (B) MHP36 cells stained for MAP-2 (neurons). (C) Signif
on the left side of Y-axis, solid red and blue bars) and number of MAP-
when compared to vehicle group. Staining for (D, E) GFAP (astrocy
(microglia) in animals receiving vehicle and MHP36 cells respectivel
(represented on left side of Y-axis, solid red and blue bars) an
oligodendrocytes or microglia respectively (right side of Y-axis, che
(*pb0.05; ns=not-significant, scale bars for A, B and D, E=100 μm;mouse model in behavioural assay to better study potential
functional effects of stem cells, enabling future studies on
potential functional effects in mouse mutants that target
particular signalling/developmental pathways for dissecting
molecularmechanisms of stemcells. Neuronal connections are
continuously remodelled and suffer intense adaptive func-
tional and structural reorganisation after lesions (Carmichael,
2003; Giraldi-Guimaraes et al., 2009; Rossi et al., 2007). This
restorative reorganisation is one of the most important
mechanisms underlying functional recovery as described
below.
Since topography of our lesion includes cortical and sub-
cortical areas, motor impairments of limb functioning and
placing deficits were evaluated in the present study by foot
fault test which has commonly been used as an efficient and
sensitive test strategy for chronic assessment of skilled fore-
and hind-limb stepping in mice (Farr et al., 2006). This is the
first study to show a significant improvement in stepping, at
28 days post-MCAO in mice receiving MHP36 cells. The
improved functional recovery observed in the present work
might be explained in part by a positive effect of the MHP36
cells in the structural plasticity induced by ischaemia. Wong
et al. showed an increase in APO-E expression in rats with
focal ischaemia relative to controls which was furthert-MCAO. Peri-lesion region of interest in the mice injected with
icant difference was observed in the mean intensity (represented
2 positive neurons (right side of Y-axis, checks red and blue bars)
tes), (G, H) CNPase (oligodendrocytes (oligo)) and (J, K) IBA-1
y. No significant difference was observed in the mean intensity
d the number of GFAP, CNPase or IBA-1 positive astrocytes,
cks red and blue bars) when compared to vehicle group (F, I, L)
for G, H=20 μm and for J, K=10 μm).
19Conditionally immortalised neural stem cells promote functional recovery and brain plasticityelevated in MHP36 grafted rats. This has been interpreted as
an indirect evidence for remodelling of circuits (Wong et al.,
2005). Thus to analyse this hypothesis, we studied the
expression of synaptophysin and GAP-43 protein related to
structural plasticity and axonal projections in the peripheryof the lesion and in the contralateral (homologous) cortex.
Our results showed a significant effect of the MHP36
treatment in the expression of synaptophysin and GAP-43
compared to vehicle suggesting that the observed recovery
might be attributed to significant plastic structural changes
20 S. Patkar et al.involving synapse formation and axonal projections. The
increased synaptogenesis in the ipsilateral cortex compared
to contralateral cortex may also at least in part explain the
asymmetric bias for impaired limb in cylinder test in MHP36
mice. In agreement, Shen et al. in 2006 showed an increase
of the synaptophysin expression in the periphery of the
ischaemic lesion in rats treated with bone-marrow stromal
cells one day after MCAO (Shen et al., 2006). In terms of the
mechanisms involved in increased synaptogenesis there are
at least two possibilities: (1) that grafted MHP36 cells
migrate to the area of damage and reconstitute local circuits
that are sufficient to promote synaptogenesis and sustain
some functions and (2) that grafts augment spontaneous
reorganisation within the host environment sufficient to
undertake, or compensate for, some lost function. We found
co-localisation of Syn/PKH26 and GAP-43/PKH26 which on
one handmaymerely indicate the presence of these epitopes
on grafted cells but on the other hand may indicate that the
former of the two possibilities above occurs in our studies. In
any case evidence from imaging studies suggests that both
possibilities are reasonable (Cramer et al., 1997).
Whether transplanted cells reduce death of host cells is
an important observation as enhanced recovery of function
could result from neuroprotection (Shen et al., 2010). The
lesion volume in the present study was not significantly
reduced by MHP36 cell which was in agreement with Modo
et al. where they showed no difference in lesion when
transplantation was 2–3 weeks post-MCAO and lesion
assessed at 14 weeks (Modo et al., 2002a). In other studies,
MHP36 cells have been shown to reduce lesion size in rats
(Veizovic et al., 2001; Modo et al., 2009). This was observed
11 months after transplantation of MHP36 grafts and may be
due to the reduction of secondary degeneration and atrophy
(Schallert et al., 1982), as reduction was not observed
3 months after transplantation, which already exerted
positive effects on bilateral asymmetry. Other mechanisms
of reconstituting local circuits by MHP36 could include filling
out of cavities (Bible et al., 2009). However, in the present
study it would not be possible for injections of 1 μl (25,000
cells) to fill out cavities averaging ~2–3 mm3, particularly
since only a third of the cells migrate to the lesion side
(Veizovic et al., 2001).
In terms of whether MHP36 grafts augment spontaneous
reorganisation within the host environment, this could be
induced by replacing lost cells and integration of MHP36 cells
into host circuitry. We found a significant effect of MHP36 on
expression of MAP-2 (neuronal) similar to Wong et al. (2005)
that showed, MHP36 cells differentiate into neurons after
global ischaemia in mice after 28 days. However we found no
effect of MHP36 on expression of CNPase (oligodendrocytes),
GFAP (astrocytes), IBA-1 (microglia) when compared to
vehicle at 28 days post-MCAO. On the other hand, Hodges
et al. (2000a) has shown that astrocytes may play an
important role in the functional recovery induced by
MHP36 grafts, since grafted cells readily adopted this
phenotype after MCAO. Reasons for these discrepancies
with our results are unclear but cell specific differentiation is
likely affected by location of injury and whether injury is
diffuse or focal. In addition we could not co-localise the
differentiation markers with PKH26 labelled cells since we
observed increased auto-fluorescence of the host brain after
MCAO. This could be partly explained by accumulation oflipofuscin granules. Lipofuscin accumulation is age-related
and may result from the gradual failure of the cell's recycling
systems and eventual death (Billinton and Knight, 2001)
caused by infarction. In addition, we stained brain sections
at Bregma 0.38±0.1 mm, which meant that there were very
few or no PKH26 labelled cells. This was not the case for Syn
and GAP-43 immunoreactivity since sections closer to the
injection were stained (Bregma 0.28±0.1 mm). Further-
more, the major drawback for the use of the lipophilic dye,
such as PKH26, has been recently pointed out by Lassailly and
group who discuss the suitability of this class of lipophilic cell
dyes for use as a cell marker and report that these dyes can
transfer (including PKH26) to neighbouring cells both in vitro
and in vivo (Lassailly et al., 2010). But we chose to use PKH26
dye for two reasons; 1) majority of work with MHP36 has
been done with PKH26 and therefore it helps to establish
consistency with previous reports and 2) incorporation into
the membrane of cells is stable and easy in vitro pre-
transplantation due to its chemical property.
Limitations for neural stem/progenitor cells include in
vitro expansion for transplantation as well as loss of capacity
to differentiate when expanded in vitro which limit their
ability to form functional grafts (Svendsen et al., 1996) with
lack of generation of specific cell types such as dopaminergic
neurons (Bjorklund et al., 2002; Roy et al., 2006; Takagi
et al., 2005) or motor neurons (Plachta et al., 2004). Still,
neural stem cells have many advantages over other cells.
Limitations of other cells include ethical concerns, limited
availability (Wechsler, 2004) and potential tumour formation
using embryonic stem cells (Erdo et al., 2003); insufficient
yield with endothelial progenitor cells (Rouhl et al., 2008)
and mesenchymal cells (Rubio et al., 2005; Tolar et al.,
2007); and the possibility for onco-genesis due to insertional
mutagenesis that is inherent to stable genomic integration
using retroviral or lentiviral vectors has been identified
as a limitation using induced pluripotent stem cells (iPS)
(Yamashita et al., 2011). Conditionally immortalised neural
cell lines circumvent these limitations since they are
capable of being maintained in vitro indefinitely and these
cell lines are multipotent in nature, thus capable of
repairing many different types of brain damage (Gray et
al., 1999) and differentiating into different types of cells;
neurones, astrocytes and oligodendrocytes (Mellodew et al.,
2004).
In the present study, we chose MHP36 cell line specifically
for their capacity not to proliferate in vivo and since human
equivalent neural stem cell line (conditionally immortalised
using mycER) are currently in phase one clinical trial in the
UK (Mack, 2011). It is important to recognise that these cells
have transformed in nature, due to long-term culturing, even
though they are potentially restricted by temperature and
that they have a distinct molecular expression profile with
high growth factor production (Mi et al., 2005). However our
findings complement other stem cell work in mice. For
example, stem cells have been shown to improve functional
recovery in mice using other immortalised neural stem cells
(Lee et al., 2007a) and using stem cells from other sources
such as bone marrow non-haemotopoietic cells (Li et al.,
2000) and, in agreement with our results, have been shown to
be effective possibly by increasing neuronal differentiation
(Lee et al., 2007b; Li and Chopp, 2009) and synaptogenesis
(Li and Chopp, 2009).
Figure 7 Histological assessment of synaptogenesis and axonal projections at 28 days post-MCAO. Peri-lesion region of interest in
animals receiving (A) vehicle and (B) MHP36 cells stained with synaptophysin (scale bar=100 μm). (C) At a higher magnification, MHP36
cells labelled with PKH26 dye (red) co-localised with Syn positive cell (green). GAP-43 positive staining in animals receiving (D) vehicle
and (E) MHP36 cells (scale bar=20 μm) and at higher magnification (F) showing MHP36 cells labelled with PKH26 dye (red) co-localised
with GAP-43 positive ce\ll (green) observed in the peri-lesion at 28 days post-MCAO (scale bar for C, F=5 μm). (G) Significant
difference was observed in the mean average intensity for Syn positive staining between animals receiving vehicle and MHP36 cells
(left side of Y-axis, solid red (vehicle) and blue (MHP36) bars) and in the number of Syn positive cells observed in a set field of view
(right side- of y-axis, checks red (vehicle) and blue (MHP36) bars). (H) Significant difference was observed in the mean average
intensity for GAP-43 staining between animals receiving vehicle and MHP36 cells (left side of Y-axis, solid red (vehicle) and blue
(MHP36) bars) as well as in the number of GAP-43 positive cells (right side of Y-axis, checks red (vehicle) and blue (MHP36) bars) at
28 days post-MCAO (*pb0.05, **pb0.01, ***pb0.001 contralateral versus ipsilateral hemisphere; #pb0.05, ##pb0.01, ###pb0.001
vehicle versus MHP36 in ipsilateral hemisphere) (I = ipsilateral; C = contralateral).
21Conditionally immortalised neural stem cells promote functional recovery and brain plasticityPrevious studies have implanted stem cells at various time
points from 24 h to 2–3 weeks (Modo et al., 2002a,b; Ikeda et
al., 2005) post-MCAO. This is the first time MHP36 have been
implanted at 48 h post-MCAO in mice. The 48 h time point is
late enough to avoid stem cell effects when the lesion is still
evolving and to allow full anaesthetic recovery between
surgeries and early enough to promote brain plasticity
resulting in recovery of function (e.g. Ikeda et al., 2005).Conclusions
In conclusion, the results suggest that MHP36 grafts
ipsilateral to lesion exert a positive functional effect
observed using the cylinder and ladder test. Increased
MAP-2, synaptophysin and GAP-43 expression in animals
receiving MHP36 cells suggests that complex processes of
neuronal differentiation and synaptogenesis are activated,
22 S. Patkar et al.whether by autocrine or paracrine effect are yet to be
elucidated. Therefore the use of transgenic mice could help
tease out the mechanisms clearly in the future.
Methods
Subjects
Forty-two males, 12–14 weeks old, C57BL/6 mice (Charles
River, UK), weighing between 25 and 30 g, were used. The
animals were housed in a controlled environment with a
12:12 h light cycle beginning at 06:00 and temperature
maintained at 22 °C. The mice were allowed ad libitum access
to food and water. The experiment was conducted complying
with the UK Animals (Scientific Procedures) Act, 1986 and
associated guidelines for the use of experimental animals.
Surgery and measurement of cerebral blood flow
Following completion of baseline testing, focal ischaemia was
inducedwithin the left hemisphere by transient (45 min)MCAO
as described previously (McColl et al., 2007). The following
occlusion time was used after a pilot study was carried out in
order to acquire cortical as well as striatal damage. Briefly,
mice were anaesthetised with 3% isoflurane (BIMEDA-MTC
Animal Health Incorporated) mixed with 1% oxygen and
maintained with 1.5±0.25% isoflurane. The core body tem-
perature was regulated at 37±0.5 °C and a 7–0 silicone
monofilament (Doccol, Ltd.) was introduced into the external
carotid artery and advanced along the internal carotid artery
(ICA) until occluding the origin of the MCA. Animals were
maintained on 1.25% isoflurane during the occlusion time.
After 45 min, the filament was withdrawn to establish
reperfusion. Sham-operated mice underwent the same proce-
dure except the filament was not advanced along the ICA.
In each animal, laser Doppler flowmetry (Moor Instru-
ments) was used to monitor cerebral blood flow (CBF)
continuously, before and during MCAO as well as during
reperfusion. Briefly, a small incision of the skin overlying the
temporalis muscle was made and a 0.7 mm, flexible, laser
Doppler probe (model P10; Moor Instruments) was positioned
on the superior portion of the temporal bone and secured
with glue. This position corresponded to the MCA territory.
Animals were included only when CBF was reduced by ≥85%
during ischaemia, and successful reperfusion was subse-
quently achieved. No animal was excluded on these criteria.
Cell maintenance and transplantation
MHP36 cells were cultured from frozen stock and maintained
in an undifferentiated state at 33 °C (Passage numbers 53–
65) (Sinden et al., 1997). Before grafting, cells were labelled
with the membrane bound fluorescent marker PKH26
(Sigma). Labelled cells were suspended in 1 mM N-acetyl-l-
cysteine (NAC) in Hank's balanced salt solution without Ca 2+
or Mg2+ at a concentration of 25,000 cells/μl. Cells were
aspirated to form a single cell suspension and checked for
incorporation of the PKH26 label prior to grafting. Viability
was assessed using trypan blue exclusion in a haemocyt-
ometer. Pre-graft viability averaged 90% and post-graftviability averaged 78%. Two days post-MCAO or sham surgery,
mice were randomly selected to receive a unilateral cortical
and striatal graft of either MHP36 stem cells (n=8) or vehicle
(NAC solution) (n=8). Mice were anaesthetised with isoflur-
ane (3% induction, 1.5% maintenance) in a mixture of oxygen
and mounted on a stereotaxic frame. Using Bregma as a
reference point, a 2-μl Hamilton syringe was moved to
the following coordinates (Medial/Lateral+2 mm, Anterior/
Posterior−0.26 mm). A burr hole was made, the dura was
removed and the syringe was descended to a depth of −1.5
and 3 mm from the surface of the brain. Cell suspension or
vehicle (0.5 μl per site of injection; cortex and caudate) was
injected over 2 min, and the syringe was left in place for
another 2 min. Treatment for immunosupression was not
carried out in the present study because Modo et al.(2002b)
showed that survival of MHP36 grafts was not affected by
immunosupression.
Experimental design
The mice were handled extensively and habituated to the
testing location and apparatus prior to training and testing
(Fig. 1). Baseline (pre-surgery) testing was performed by
placing the animals for two crossings on the ladder rung task
with a set rung arrangement pattern (irregular). Mice under-
went MCAO and received either the vehicle or MHP36 cells
2 days post-surgery. Behavioural testing and video recording of
both ladder-rung and cylinder test occurred immediately after
transplantation (2 days post-MCAO) and on 7, 14 and 28 days
post-surgery. For all analyses, the experimenter was blinded
to which treatment mice received (Fig. 1).
Clark's deficit score (CDS)
One, three and four days after the induction of ischaemia, each
mouse was rated on two neurologic function scales unique to
the mouse (Clark et al., 1997) to establish severity of deficit.
Scores for both scales range from 0 (healthy) to 28 and
represent the sumof the results of all categories for each scale.
The general deficit scale evaluates hair (0–2), ears (0–2), eyes
(0–4), posture (0–4), spontaneous activity (0–4), and epileptic
behaviour (0–12), whereas the focal deficit scale evaluates
body symmetry (0–4), gait (0–4), climbing on a surface held at
45° (0–4), circling behaviour (0–4), front limb symmetry (0–4),
compulsory circling (0–4) andwhisker response to a light touch
(0–4) (De Simoni et al., 2003). Animals that recieved a score
>21 on the focal deficit scale were excluded from the study.
Out of the 42 animals that underwent MCAO, 10 were excluded
on this criteria.
Ladder rung task apparatus and analysis
The ladder rung task was adapted from the ladder rung
walking task used previously in rats (Metz and Whishaw,
2002). The ladder rung apparatus was composed of two
Plexiglas walls (69.5 cm×15 cm). Each wall contained 121
holes 0.20 cm diameter, spaced 0.5 cm apart, and located
1 cm apart from the bottom edge of the wall (Farr et al.,
2006). The holes could be filled with 8 cm long metal bars,
diameter 0.10 cm in any pattern. The walls were spaced 5 cm
apart to allow for passage of a mouse but prevent it from
23Conditionally immortalised neural stem cells promote functional recovery and brain plasticityturning around. The entire apparatus was placed atop two
standard mouse housing cages, 17 cm above the ground.
Animals were tested in an irregular pattern in which the
distance of the rungs varied, ranging from 0.5 to 2.5 cm.
Each post-MCAO test session included two crossings on the
ladder. The animals' performance was video-recorded from
the side, with the camera positioned at a slight ventral angle
to allow all four limbs being recorded at the same time. All
video recordings were analysed frame-by-frame. Each of the
four limbs was scored for placement errors with each step
being scored. However, the first two initiation steps and last
two final steps were omitted when an animal paused. Each
step was scored according to the quality of limb placement
based on the scale adapted from Metz and Whishaw (2002).
Cylinder task apparatus and analysis
The cylinder or spontaneous forelimb test modified for
mouse (Baskin et al., 2003), involves the use of a 10 cm
diameter transparent cylinder. Each animal was placed in
the cylinder, and its spontaneous activity to rear up on its
hind limbs and explore the vertical surface with its forelimbs
was observed. Animals used either a single forelimb or both
forelimbs for an exploration. The number of both, right only,
or left only explorations was counted in a two-minute
recording interval. One pre-injury measurement was taken
to control for limb preference. The asymmetric score
(Schallert et al., 2000) was computed as follows:
# of right only−# of left onlyð Þ
= # of right only þ # of left only þ # of bothð Þ:
Normal uninjured performance, for an animal with no
preference for right or left forelimb, is at or near zero.
Animals showed a tendency, in the measurements at 2 days
injury, to explore the cylinder less frequently and to spend a
larger proportion of time engaged in grooming activities.
Additional two minute trials were performed until at least 10
rearing observations were made.
Video recording and analysis equipment
The mice were filmed with a high speed Panasonic digital
camcorder (30 frames/s; shutter speed of 1/1000). The digital
videotapes were analyzed using a HP Pavilion DV2000 laptop.
Single frames were imported from the digital video records
using Windows media player on a Windows operating system.
Histology and lesion measurement
Twenty-eight days post-MCAO, mice were perfused through
the heart with 0.9% physiological saline followed by 4%
paraformaldehyde. The brains were removed and cryo-
protected in a 30% sucrose solution. The tissue was placed
in a 2800 Frigocut E cryostat (Reichert–Jung) and sectioned
in 20 μm thick sections. Eight coronal levels were selected
from the mouse atlas (1.6, 1.1, 0.14, −0.38, −1.0, −1.9,
−3.0, −4.0 mm with respect to Bregma, based on Osborne
et al. (1987), modified for mouse). Distinct neuroanatomical
landmarks defined which sections were chosen for the 8 pre-
selected coronal levels which were then stained withhaematoxylin and eosin. For volumetric assessment of
ischaemic damage, the observer was unaware of treatment
(injection). Areas of ischaemic damage were delineated onto
scaled diagrams representing the eight coronal levels and
then measured by means of an MCID image-analysis system.
Approximation of the total volume (mm3) of ischaemic
damage was achieved by integration of areas (mm2) with the
distance between each coronal level (mm). The end points
for integration were 2.9 mm (rostral limit) and −4.9 mm
(caudal limit) with respect to Bregma.
Serial 20 μm coronal sections were processed for immu-
nostaining with chicken anti-microtubule-associated protein
(MAP-2, 1:500, Chemicon, UK), mouse anti-glial fibrillary
acidic protein (GFAP, 1:200, Sigma,UK),mouse anti-CNPase (2′,
3′-cyclic-nucleotide 3′-phosphodiesterase) (1:200, Chemicon,
UK) and goat anti-IBA-1 (ionised calcium binding adaptor
molecule 1, 1:500, Abcam Plc., UK) to identify various
populations of neural cells. Mouse anti-synaptophysin (Syn,
1:200, Abcam Plc., UK) was used to investigate synaptogenesis
and anti-rabbit GAP-43 (1:200, Abcam Plc., UK) was used as a
marker for axonal projections. Sections were incubated
overnight at 4 °C and followed with application of secondary
antibody, raised against chicken IgG bound to Alexafluor 488
(Chemicon, UK),mouse IgG bound to fluorescein isothiocyanate
(FITC) (Sigma-Aldrich, UK) at a dilution of 1:100 in PBS for 1 h.
Afterwashing in PBS, cover slipsweremountedwithVectashield
with DAPI (Vector Labs) and viewed and photographed using a
Nikon EclipesE600 Oil Immersion microscope connected to a
photometrics (CoolSnapFx) digital camera managed by Meta-
Morph software. A negative control was included in every run
which included no primary antibody incubation.
Three animal brains were randomly stained for the
different markers to avoid bias selection. During image
acquisition, the threshold and gain on the confocal laser
microscope were set using the control for each run of staining.
This helped to subtract the background fluorescence. Cells
positive for each marker were quantified by counting the
number of positive cells and directly compared to vehicle
group. In addition, the average intensity in the region of
interest (ROI) per area of field of view for eachmarkerwas also
measured to allow semi-quantitative comparison between
MHP36 and vehicle treated animals using Image J software.
The obtained values used for graphical representation are a
ratio of intensity and area. ROI for differentiation consisted of
the ipsilateral striatum and somatosensory cortex within each
brain. ROI for synaptic plasticity consisted of the ipsilateral
striatum and somatosensory cortex and contralateral striatum
and somatosensory cortex within each brain (Bregma 0.3±
0.1 mm). Two imageswere taken in eachROI for quantification.
No comparisons were made between the cortex and striatum.
The images were acquired using a Leica Epi-fluorescence
microscope (Leica Microsystems, Wetzlar, Germany) with
200×, 400× and 100× oil-immersion objectives connected to
Metamorph-Pro software.
Statistical analysis
Statistical comparisons in all behavioural tests were made
using repeated measures ANOVA. Two way ANOVA with a post
hoc Bonferroni's test to correct for multiple comparisons
(three factors; surgery, time and injection) was used unless
otherwise stated.
24 S. Patkar et al.In histological and molecular assessments, unpaired t-test
was performed unless otherwise stated. A p-value of less
than 0.05 was chosen as the significance level for all
statistical analyses. All data are presented as mean
±standard error of the mean (S.E.M.).
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